Search Results

Exploring genetic factors involved in huntington disease age of onset. E2F2 as a new potential modifier gene

• Authors : Valcárcel Ocete, Leire; Alkorta Aranburu, Gorka; Iriondo, Mikel ...

Subjects: adult; age of onset; aged

Record details

Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease

• Authors : Rusz J.; Saft C.; Schlegel U.

Subjects: Huntington disease; prodromal; speech disorder

Record details

Does arterial hypertension influence the onset of Huntington's disease?

• Authors : Valcárcel-Ocete, Leire¹; Fullaondo, Asier¹; Alkorta-Aranburu, Gorka²

Subjects: *Huntington disease; *Huntingtin protein; *Neurodegeneration

• Source: PLoS ONE. 5/23/2018, Vol. 13 Issue 5, p1-11. 11p.

Record details

Bupropion for the treatment of apathy in Huntington’s disease: A multicenter, randomised, double-blind, placebo-controlled, prospective crossover trial.

• Authors : Gelderblom, Harald¹; Wüstenberg, Torsten²; McLean, Tim³

Subjects: *Apathy; *Huntington's chorea treatment; *Bupropion

• Source: PLoS ONE. 3/21/2017, Vol. 12 Issue 3, p1-17. 17p.

Record details

Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene.

• Authors : Valcárcel-Ocete, Leire¹; Alkorta-Aranburu, Gorka²; Iriondo, Mikel¹

Subjects: *Huntington disease; *Exons (Genetics); *Regression analysis

• Source: PLoS ONE. 7/6/2015, Vol. 10 Issue 7, p1-14. 14p.

Record details

Phonatory Dysfunction as a Preclinical Symptom of Huntington Disease.

• Authors : Rusz, Jan^1,2; Saft, Carsten³; Schlegel, Uwe⁴

Subjects: *Voice disorders; *Symptoms; *Huntington's chorea treatment

• Source: PLoS ONE. Nov2014, Vol. 9 Issue 11, p1-7. 7p.

Record details

Efficacy of Fumaric Acid Esters in the R6/2 and YAC128 Models of Huntington's Disease.

• Authors : Ellrichmann, Gisa¹; Petrasch-Parwez, Elisabeth²; De-Hyung Lee¹

Subjects: *Medical research; *Huntington disease; *Dementia

• Source: PLoS ONE. 2011, Vol. 6 Issue 1, p1-11. 11p.

Record details

Correction: Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice.

• Authors : Rogier R; Ederveen THA; Wopereis H

• Source: PloS one [PLoS One] 2019 Dec 31; Vol. 14 (12), pp. e0227517. Date of Electronic Publication: 2019 Dec 31 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details

Associations of stunting in early childhood with cardiometabolic risk factors in adulthood.

• Authors : De Lucia Rolfe, Emanuella¹ ; de França, Giovanny Vinícius Araújo²; Vianna, Carolina Avila²

Subjects: *Heart metabolism disorders; *Juvenile diseases; *Obesity complications

• Source: PLoS ONE. 4/11/2018, Vol. 13 Issue 4, p1-13. 13p.

Record details

Supplementation of diet with non-digestible oligosaccharides alters the intestinal microbiota, but not arthritis development, in IL-1 receptor antagonist deficient mice.

• Authors : Rogier R; Experimental Rheumatology, Radboudumc, Nijmegen, The Netherlands.; Ederveen THA

Subjects: Arthritis, Experimental/Arthritis, Experimental/Arthritis, Experimental/*pathology ; Gastrointestinal Microbiome/Gastrointestinal Microbiome/Gastrointestinal Microbiome/*drug effects ; Interleukin 1 Receptor Antagonist Protein/Interleukin 1 Receptor Antagonist Protein/Interleukin 1 Receptor Antagonist Protein/*genetics

• Source: PloS one [PLoS One] 2019 Jul 08; Vol. 14 (7), pp. e0219366. Date of Electronic Publication: 2019 Jul 08 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection

Record details